Skip to main content
. 2020 Sep;41(9):1599–1605. doi: 10.3174/ajnr.A6757

Table 1:

Clinical characteristics of the study patients

All Patients(n = 98) CCF Positive Patients (n = 38) CCF Negative Patients (n = 60)
Sex, n
    Male/Female 32/66 11/27 21/39
Age, years
    Mean (range) 54.6 (20–85) 66.0 (24–85) 51.4 (20–81)
Symptoms, n (%)
    Diplopia 54 (55.1) 20 (52.6) 34 (56.7)
    Eyeball pain 27 (27.6) 14 (36.8) 13 (21.7)
    Facial pain 2 (2.0) 1 (2.6) 1 (1.7)
    Ptosis 30 (30.6) 8 (21.1) 22 (36.7)
    Proptosis 14 (14.3) 9 (23.7) 5 (8.3)
    Periorbital swelling 19 (19.4) 16 (42.1) 3 (5)
    Conjunctival injection 23 (23.5) 16 (42.1) 7 (11.7)
    Visual disturbance 18 (18.4) 7 (18.4) 11 (18.3)
    Headache 40 (40.8) 14 (36.8) 26 (43.3)
    Dizziness 13 (13.3) 5 (13.2) 8 (13.3)
Neurologic signs, n (%)Laterality
        Right 30 (30.6) 8 (21.1) 22 (36.7)
        Left 22 (22.4) 6 (15.8) 16 (26.7)
    3rd cranial neve palsy 26 (26.5) 4 (10.5) 22 (36.7)
    4th cranial nerve palsy 5 (5.1) 2 (5.3) 3 (5)
    6th cranial nerve palsy 22 (22.4) 8 (21.1) 14 (23.3)
Trauma history, n (%) 5 (5.1) 3 (7.9) 2 (3.3)